Terms: = Leukemia AND FCGR2B, FCGR2, 2213, ENSG00000072694, CD32, CD32B, P31994, IGFR2, FCG2
64 results:
1. Anti-Vα24Jα18 TCR Antibody Tunes iNKT Cell Responses to Target and Kill CD1d-negative Tumors in an FcγRII (cd32)-dependent Manner.
Takami M; Aoki T; Nishimura K; Tanaka H; Onodera A; Motohashi S
Cancer Res Commun; 2024 Feb; 4(2):446-459. PubMed ID: 38319156
[TBL] [Abstract] [Full Text] [Related]
2. CMV reactivation after allogeneic HCT is associated with a reduced risk of relapse in acute lymphoblastic leukemia.
Akahoshi Y; Nakasone H; Takenaka K; Yamasaki S; Nakamura M; Doki N; Tanaka M; Ozawa Y; Uchida N; Ara T; Nakamae H; Ota S; Onizuka M; Yano S; Tanaka J; Fukuda T; Kanda Y; Atsuta Y; Kako S; Yanada M; Arai Y
Blood Adv; 2023 Jun; 7(12):2699-2708. PubMed ID: 36661335
[TBL] [Abstract] [Full Text] [Related]
3. A cytotoxic effect of human lactoferrin fusion with Fc domain of IgG.
Zaczyńska E; Kocięba M; Artym J; Kochanowska I; Kruzel ML; Zimecki M
Biometals; 2023 Jun; 36(3):617-627. PubMed ID: 36136256
[TBL] [Abstract] [Full Text] [Related]
4. HIF activation enhances FcγRIIb expression on mononuclear phagocytes impeding tumor targeting antibody immunotherapy.
Hussain K; Liu R; Smith RCG; Müller KTJ; Ghorbani M; Macari S; Cleary KLS; Oldham RJ; Foxall RB; James S; Booth SG; Murray T; Dahal LN; Hargreaves CE; Kemp RS; Longley J; Douglas J; Markham H; Chee SJ; Stopforth RJ; Roghanian A; Carter MJ; Ottensmeier CH; Frendéus B; Cutress RI; French RR; Glennie MJ; Strefford JC; Thirdborough SM; Beers SA; Cragg MS
J Exp Clin Cancer Res; 2022 Apr; 41(1):131. PubMed ID: 35392965
[TBL] [Abstract] [Full Text] [Related]
5. Homogeneously high expression of cd32b makes it a potential target for CAR-T therapy for chronic lymphocytic leukemia.
Wang G; Sun X; Zuo S; Li C; Niu Q; Xia Y; Meng Y; Liu M; Fang Z; Yang X; Jiang Y; Wang S; Cui H; Huang H; Jiang E; Zhou D; Deng Q; Pan J; Feng X
J Hematol Oncol; 2021 Sep; 14(1):149. PubMed ID: 34530888
[TBL] [Abstract] [Full Text] [Related]
6. Discovery of
Chen W; Chen X; Li D; Zhou J; Jiang Z; You Q; Guo X
J Med Chem; 2021 Jun; 64(12):8221-8245. PubMed ID: 34105966
[TBL] [Abstract] [Full Text] [Related]
7. Development of Anti-cd32b Antibodies with Enhanced Fc Function for the Treatment of B and Plasma Cell Malignancies.
Lu H; Molony RD; Chen D; Jang S; Wolf B; Ewert S; Flaherty M; Xu F; Isim S; Shim Y; Dornelas C; Balke N; Leber XC; Scharenberg M; Koelln J; Choi E; Ward R; Johnson J; Calzascia T; Isnardi I; Williams JA; Lindenbergh PL; van de Donk NWCJ; Mutis T; Huet H; Lees E; Meyer MJ
Mol Cancer Ther; 2020 Oct; 19(10):2089-2104. PubMed ID: 32847974
[TBL] [Abstract] [Full Text] [Related]
8. Therapeutic inhibition of FcγRIIb signaling targets leukemic stem cells in chronic myeloid leukemia.
Parting O; Langer S; Kuepper MK; Wessling C; Li S; Braunschweig T; Chatain N; Maié T; Costa IG; Crysandt M; Huber M; Brümmendorf TH; Koschmieder S; Schemionek M
Leukemia; 2020 Oct; 34(10):2635-2647. PubMed ID: 32684632
[TBL] [Abstract] [Full Text] [Related]
9. FcγRII (cd32) modulates antibody clearance in NOD SCID mice leading to impaired antibody-mediated tumor cell deletion.
Oldham RJ; Mockridge CI; James S; Duriez PJ; Chan HTC; Cox KL; Pitic VA; Glennie MJ; Cragg MS
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32554613
[TBL] [Abstract] [Full Text] [Related]
10. Fc gamma receptor expression serves as prognostic and diagnostic factor in AML.
Heitmann JS; Hagelstein I; Hinterleitner C; Osburg L; Salih HR; Kauer J; Märklin M
Leuk Lymphoma; 2020 Oct; 61(10):2466-2474. PubMed ID: 32543333
[TBL] [Abstract] [Full Text] [Related]
11. Human neutrophils express low levels of FcγRIIIA, which plays a role in PMN activation.
Golay J; Valgardsdottir R; Musaraj G; Giupponi D; Spinelli O; Introna M
Blood; 2019 Mar; 133(13):1395-1405. PubMed ID: 30655272
[TBL] [Abstract] [Full Text] [Related]
12. Imatinib trough levels: a potential biomarker to predict cytogenetic and molecular response in newly diagnosed patients with chronic myeloid leukemia.
Natarajan H; Kumar L; Bakhshi S; Sharma A; Velpandian T; Kabra M; Gogia A; Ranjan Biswas N; Gupta YK
Leuk Lymphoma; 2019 Feb; 60(2):418-425. PubMed ID: 30124353
[TBL] [Abstract] [Full Text] [Related]
13. Dengue immune sera enhance Zika virus infection in human peripheral blood monocytes through Fc gamma receptors.
Li M; Zhao L; Zhang C; Wang X; Hong W; Sun J; Liu R; Yu L; Wang J; Zhang F; Jin X
PLoS One; 2018; 13(7):e0200478. PubMed ID: 30044839
[TBL] [Abstract] [Full Text] [Related]
14. Universal monitoring of minimal residual disease in acute myeloid leukemia.
Coustan-Smith E; Song G; Shurtleff S; Yeoh AE; Chng WJ; Chen SP; Rubnitz JE; Pui CH; Downing JR; Campana D
JCI Insight; 2018 May; 3(9):. PubMed ID: 29720577
[TBL] [Abstract] [Full Text] [Related]
15. PHAGOCYTOSIS AND EXPRESSION OF FCg-RECEPTORS AND CD180 ON MONOCYTES IN CHRONIC LYMPHOCYTIC leukemia.
Tsertsvadze T; Mitskevich N; Bilanishvili A; Girdaladze D; Porakishvili N
Georgian Med News; 2017 Sep; (270):88-93. PubMed ID: 28972490
[TBL] [Abstract] [Full Text] [Related]
16. FcγRIIb expression in early stage chronic lymphocytic leukemia.
Bosch R; Mora A; Vicente EP; Ferrer G; Jansà S; Damle R; Gorlatov S; Rai K; Montserrat E; Nomdedeu J; Pratcorona M; Blanco L; Saavedra S; Garrido A; Esquirol A; Garcia I; Granell M; Martino R; Delgado J; Sierra J; Chiorazzi N; Moreno C
Leuk Lymphoma; 2017 Nov; 58(11):2642-2648. PubMed ID: 28372509
[TBL] [Abstract] [Full Text] [Related]
17. A Promyelocytic leukemia Protein-Thrombospondin-2 Axis and the Risk of Relapse in Neuroblastoma.
Dvorkina M; Nieddu V; Chakelam S; Pezzolo A; Cantilena S; Leite AP; Chayka O; Regad T; Pistorio A; Sementa AR; Virasami A; Barton J; Montano X; Lechertier T; Brindle N; Morgenstern D; Lebras M; Burns AJ; Saunders NJ; Hodivala-Dilke K; Bagella L; De The H; Anderson J; Sebire N; Pistoia V; Sala A; Salomoni P
Clin Cancer Res; 2016 Jul; 22(13):3398-409. PubMed ID: 27076624
[TBL] [Abstract] [Full Text] [Related]
18. Expression and Role of the ErbB3-Binding Protein 1 in Acute Myelogenous Leukemic Cells.
Nguyen le XT; Zhu L; Lee Y; Ta L; Mitchell BS
Clin Cancer Res; 2016 Jul; 22(13):3320-7. PubMed ID: 26813358
[TBL] [Abstract] [Full Text] [Related]
19. Correlation of the expression of cd32 and CD180 receptors on CLL cells and MEC1 cell line.
Tsertsvadze T; Mitskevich N; Ghirdaladze D; Porakishvili N
Georgian Med News; 2015 Mar; (240):56-9. PubMed ID: 25879560
[TBL] [Abstract] [Full Text] [Related]
20. Aberrant expression of Fcγ-receptors and Toll like receptor CD180 on monocytes from patients with chronic lymphocytic leukaemia.
Tsertsvadze TSh; Mitskevich NG; Ghirdaladze DM; Porakishvili NZ
Georgian Med News; 2015 Feb; (239):35-8. PubMed ID: 25802446
[TBL] [Abstract] [Full Text] [Related]
[Next]
